Latest News by Industry
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Tuesday reported a loss of $516.8 million in its first quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $5.86. Losses, adjusted for one-time gains and costs, came to 97 cents per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.46 per share.
The biopharmaceutical company posted revenue of $253.5 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $223.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a SRPT">Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT